313 related articles for article (PubMed ID: 23033547)
1. Barriers to therapeutic clinical trials enrollment: differences between African-American and white cancer patients identified at the time of eligibility assessment.
Penberthy L; Brown R; Wilson-Genderson M; Dahman B; Ginder G; Siminoff LA
Clin Trials; 2012 Dec; 9(6):788-97. PubMed ID: 23033547
[TBL] [Abstract][Full Text] [Related]
2. Racial/ethnic differences in clinical trial enrollment, refusal rates, ineligibility, and reasons for decline among patients at sites in the National Cancer Institute's Community Cancer Centers Program.
Langford AT; Resnicow K; Dimond EP; Denicoff AM; Germain DS; McCaskill-Stevens W; Enos RA; Carrigan A; Wilkinson K; Go RS
Cancer; 2014 Mar; 120(6):877-84. PubMed ID: 24327389
[TBL] [Abstract][Full Text] [Related]
3. Factors associated with breast cancer clinical trials participation and enrollment at a large academic medical center.
Simon MS; Du W; Flaherty L; Philip PA; Lorusso P; Miree C; Smith D; Brown DR
J Clin Oncol; 2004 Jun; 22(11):2046-52. PubMed ID: 15082724
[TBL] [Abstract][Full Text] [Related]
4. Race and Health Disparities in Patient Refusal of Surgery for Early-Stage Pancreatic Cancer: An NCDB Cohort Study.
Tohme S; Kaltenmeier C; Bou-Samra P; Varley PR; Tsung A
Ann Surg Oncol; 2018 Nov; 25(12):3427-3435. PubMed ID: 30043318
[TBL] [Abstract][Full Text] [Related]
5. Perceptions of participation in a phase I, II, or III clinical trial among African American patients with cancer: what do refusers say?
Brown RF; Cadet DL; Houlihan RH; Thomson MD; Pratt EC; Sullivan A; Siminoff LA
J Oncol Pract; 2013 Nov; 9(6):287-93. PubMed ID: 24130251
[TBL] [Abstract][Full Text] [Related]
6. Race and health disparities in patient refusal of surgery for early-stage non-small cell lung cancer: a SEER cohort study.
Mehta RS; Lenzner D; Argiris A
Ann Surg Oncol; 2012 Mar; 19(3):722-7. PubMed ID: 21947698
[TBL] [Abstract][Full Text] [Related]
7. Reasons for HCV non-treatment in underserved African Americans: implications for treatment with new therapeutics.
Schaeffer S; Khalili M
Ann Hepatol; 2015; 14(2):234-42. PubMed ID: 25671833
[TBL] [Abstract][Full Text] [Related]
8. Eligibility Criteria Perpetuate Disparities in Enrollment and Participation of Black Patients in Pancreatic Cancer Clinical Trials.
Riner AN; Girma S; Vudatha V; Mukhopadhyay N; Skoro N; Gal TS; Freudenberger DC; Herremans KM; George TJ; Trevino JG
J Clin Oncol; 2022 Jul; 40(20):2193-2202. PubMed ID: 35316089
[TBL] [Abstract][Full Text] [Related]
9. Race, treatment preferences, and hospice enrollment: eligibility criteria may exclude patients with the greatest needs for care.
Fishman J; O'Dwyer P; Lu HL; Henderson HR; Asch DA; Casarett DJ
Cancer; 2009 Feb; 115(3):689-97. PubMed ID: 19107761
[TBL] [Abstract][Full Text] [Related]
10. Examining Differences in Opportunity and Eligibility for Cancer Clinical Trial Participation Based on Sociodemographic and Disease Characteristics.
Rearden J; Hanlon AL; Ulrich C; Brooks-Carthon M; Sommers M
Oncol Nurs Forum; 2016 Jan; 43(1):57-66. PubMed ID: 26679445
[TBL] [Abstract][Full Text] [Related]
11. Race, medical researcher distrust, perceived harm, and willingness to participate in cardiovascular prevention trials.
Braunstein JB; Sherber NS; Schulman SP; Ding EL; Powe NR
Medicine (Baltimore); 2008 Jan; 87(1):1-9. PubMed ID: 18204365
[TBL] [Abstract][Full Text] [Related]
12. Communicating Effectively About Clinical Trials With African American Communities: A Comparison of African American and White Information Sources and Needs.
Tanner A; Bergeron CD; Zheng Y; Friedman DB; Kim SH; Foster CB
Health Promot Pract; 2016 Mar; 17(2):199-208. PubMed ID: 26715695
[TBL] [Abstract][Full Text] [Related]
13. The Role of Transportation in the Enrollment of Elderly African Americans into Exercise and Memory Study: GEMS Study.
Graham L; Ngwa J; Ntekim O; Ogunlana O; Johnson S; Nadarajah S; Fungwe TV; Turner J; Ruiz MR; Khan J; Obisesan TO
J Racial Ethn Health Disparities; 2023 Aug; 10(4):1837-1845. PubMed ID: 35931916
[TBL] [Abstract][Full Text] [Related]
14. Eligibility criteria and enrollment of a diverse racial and ethnic population in multiple myeloma clinical trials.
Kanapuru B; Fernandes LL; Baines A; Ershler R; Bhatnagar V; Pulte E; Gwise T; Theoret MR; Pazdur R; Fashoyin-Aje L; Gormley N
Blood; 2023 Jul; 142(3):235-243. PubMed ID: 37140031
[TBL] [Abstract][Full Text] [Related]
15. Participation in cancer clinical trials: race-, sex-, and age-based disparities.
Murthy VH; Krumholz HM; Gross CP
JAMA; 2004 Jun; 291(22):2720-6. PubMed ID: 15187053
[TBL] [Abstract][Full Text] [Related]
16. Enrollment of African Americans onto clinical treatment trials: study design barriers.
Adams-Campbell LL; Ahaghotu C; Gaskins M; Dawkins FW; Smoot D; Polk OD; Gooding R; DeWitty RL
J Clin Oncol; 2004 Feb; 22(4):730-4. PubMed ID: 14966098
[TBL] [Abstract][Full Text] [Related]
17. Reasons for Exclusion from a Smoking Cessation Trial: An Analysis by Race/Ethnicity.
Webb Hooper M; Asfar T; Unrod M; Dorsey A; Correa JB; Brandon KO; Simmons VN; Antoni MA; Koru-Sengul T; Lee DJ; Brandon TH
Ethn Dis; 2019; 29(1):23-30. PubMed ID: 30713413
[TBL] [Abstract][Full Text] [Related]
18. Increasing and supporting the participation of persons of color living with HIV/AIDS in AIDS clinical trials.
Gwadz MV; Colon P; Ritchie AS; Leonard NR; Cleland CM; Riedel M; Bowens D; Banfield AD; Chang P; Quiles R; Mildvan D
Curr HIV/AIDS Rep; 2010 Nov; 7(4):194-200. PubMed ID: 20737252
[TBL] [Abstract][Full Text] [Related]
19. Barriers to the participation of African-American patients with cancer in clinical trials: a pilot study.
Advani AS; Atkeson B; Brown CL; Peterson BL; Fish L; Johnson JL; Gockerman JP; Gautier M
Cancer; 2003 Mar; 97(6):1499-506. PubMed ID: 12627515
[TBL] [Abstract][Full Text] [Related]
20. Racial Disparities in Hepatitis C Treatment Eligibility.
Sims OT; Pollio DE; Hong BA; North CS
Ann Hepatol; 2017; 16(4):530-537. PubMed ID: 28611273
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
